Boreo Plc has signed a deal to acquire Delfin Technologies Oy, a specialist in health technology, aiming to strengthen its position in the medical device market.

Information on the Target

Boreo Plc signed a share purchase agreement on June 8, 2023, to acquire the entire share capital of Delfin Technologies Oy, a prominent health technology firm. The acquisition involves Tapani Lahtinen, CEO Jouni Nuutinen, and a group of private shareholders, referred to as the ‘Sellers’. Delfin Technologies will continue its operations under Boreo’s Electronics Business Area, maintaining leadership with CEO Jouni Nuutinen.

Delfin Technologies, established in 1998, specializes in developing, producing, and marketing scientifically validated instruments for skin and edema measurement. The company’s products serve both clinical applications and medical research, covering a wide range of uses from dermatological assessments to R&D validation for self-care and cosmetics products. Its clinical applications have received approval for use in both the US and EU, underscoring the company's commitment to quality and compliance.

Industry Overview in Finland

The health technology sector in Finland is recognized for its innovative approach and strong emphasis on research and development. Home to an array of firms engaged in medical device development, Finland's industry